![]() Viela Bio Viela Bio is a clinical-stage biotechnology company advancing treatments for severe inflammation and autoimmune diseases. | ![]() Vita 34 Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries. | ||
Founding Date | Founding Date 2018 | Founding Date 1990 | Founding Date 1997 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ Rockville, US | Locations Stockholm, SE HQ Hiroshima Shi, JP Minato Ku, JP Singapore, SG Lund, SE Doral, US | Locations Leipzig, DE HQ Leipzig, DE |
Employees | Employees 7 | Employees 167 | Employees 771 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1 b | Valuation ($) 77.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) $11.7m (FY, 2020) | Revenue (est.) kr1.5b (FY, 2025) | Revenue (est.) €88.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods kr391m (FY, 2025) | Cost of goods €30m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit kr1.1b (FY, 2025) | Gross profit €59.8m (FY, 2025) |
Net income | Net income ($150.7m) (FY, 2020) | Net income kr332.8m (FY, 2025) | Net income (€5m) (FY, 2025) |

BioGaia is a biotechnology company that develops and sells probiotic solutions.
View company
Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries.
View company